Faron Pharmaceuticals Oy (FARN) Stock Statistics & Valuation Metrics

Faron Pharmaceuticals Oy has a market cap or net worth of £232.93M. The enterprise value is ―.

Faron Pharmaceuticals Oy has 111,954,600 shares outstanding. The number of shares has decreased by -2.65% in one year.

Faron Pharmaceuticals Oy’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Faron Pharmaceuticals Oy had revenue of ― and earned -28.73M in profits. Earnings per share was ―.

In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.

Faron Pharmaceuticals Oy pays an annual dividend of ―, resulting in a dividend yield of ―

Faron Pharmaceuticals Oy upcoming earnings date is Aug 27, 2025, TBA (Confirmed).

Faron Pharmaceuticals Oy as a current ratio of ―, with Debt / Equity ratio of ―

In the past 12 months, Faron Pharmaceuticals Oy has paid ― in taxes.

Faron Pharmaceuticals Oy EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Faron Pharmaceuticals Oy has ― in cash and marketable securities with 13.27M in debt, giving a net cash position of ― billion.

Gross margin is ―, with operating margin of ―, and net profit margin of ―.

The average price target for Faron Pharmaceuticals Oy is £685.66, which is 11.43% higher than the current price. The consensus rating is Moderate Buy